Literature DB >> 18285532

Toward a plasma marker for Alzheimer disease: some progress, but still a long way to go.

Howard A Crystal, Peter Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18285532      PMCID： PMC2895568          DOI： 10.1212/01.wnl.0000299905.05595.68

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  9 in total

Review 1.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

2.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

3.  Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

Authors:  Marieke van Oijen; Albert Hofman; Holly D Soares; Peter J Koudstaal; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

4.  Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

Authors:  Neill R Graff-Radford; Julia E Crook; John Lucas; Bradley F Boeve; David S Knopman; Robert J Ivnik; Glenn E Smith; Linda H Younkin; Ronald C Petersen; Steven G Younkin
Journal:  Arch Neurol       Date:  2007-03

5.  Selective reductions in plasma Abeta 1-42 in healthy elderly subjects during longitudinal follow-up: a preliminary report.

Authors:  Nunzio Pomara; Lisa M Willoughby; John J Sidtis; Pankaj D Mehta
Journal:  Am J Geriatr Psychiatry       Date:  2005-10       Impact factor: 4.105

6.  Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families.

Authors:  N Ertekin-Taner; L H Younkin; D M Yager; F Parfitt; M C Baker; S Asthana; M L Hutton; S G Younkin; N R Graff-Radford
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

7.  Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome.

Authors:  Nicole Schupf; Bindu Patel; Deborah Pang; Warren B Zigman; Wayne Silverman; Pankaj D Mehta; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-07

8.  Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk.

Authors:  R Mayeux; L S Honig; M-X Tang; J Manly; Y Stern; N Schupf; P D Mehta
Journal:  Neurology       Date:  2003-11-11       Impact factor: 9.910

Review 9.  Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.

Authors:  M J de Leon; L Mosconi; K Blennow; S DeSanti; R Zinkowski; P D Mehta; D Pratico; W Tsui; L A Saint Louis; L Sobanska; M Brys; Y Li; K Rich; J Rinne; H Rusinek
Journal:  Ann N Y Acad Sci       Date:  2007-02       Impact factor: 5.691
  9 in total
  4 in total

1.  A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.

Authors:  Weiming Xia; Ting Yang; Ganesh Shankar; Imelda M Smith; Yong Shen; Dominic M Walsh; Dennis J Selkoe
Journal:  Arch Neurol       Date:  2009-02

2.  Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.

Authors:  Silvia A Mandel; Micaela Morelli; Ilan Halperin; Amos D Korczyn
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

Review 3.  Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?

Authors:  Kurt A Jellinger; Bernd Janetzky; Johannes Attems; Elisabeth Kienzl
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

4.  Alzheimer's disease: new diagnostic and therapeutic tools.

Authors:  Marco Racchi; Daniela Uberti; Stefano Govoni; Maurizio Memo; Cristina Lanni; Sonya Vasto; Giuseppina Candore; Calogero Caruso; Loriana Romeo; Giovanni Scapagnini
Journal:  Immun Ageing       Date:  2008-08-13       Impact factor: 6.400
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.